Skip to Content
DR. ZULETA
Blog
Dr. Andres Zuleta
THRIVEMED
Podcast
About
0
0
DR. ZULETA
Blog
Dr. Andres Zuleta
THRIVEMED
Podcast
About
0
0
Blog
Dr. Andres Zuleta
THRIVEMED
Podcast
About
Research Decodes, Peptide Breakthroughs Samasta Admin 10/20/26 Research Decodes, Peptide Breakthroughs Samasta Admin 10/20/26

Maridebart Cafraglutide: A Physician’s Read on a Monthly GLP-1 Antibody-Peptide Conjugate

A GLP-1 agonist carried by a GIP receptor blocking antibody, dosed every 4 to 8 weeks. A short physician’s read on the design, the data and the open questions.

Read More
Research Decodes Samasta Admin 10/5/26 Research Decodes Samasta Admin 10/5/26

Frailty Should Not Preclude Semaglutide? My Read of the SELECT Frailty Analysis

A post hoc analysis of SELECT applied a 31-item frailty index to 17,604 adults. The heart benefit looked consistent across frailty levels. Here is what it shows, what it can’t, and how I would pair it with strength and protein.

Read More

DR. ZULETA

By Samasta LLC

About

Thrivemed